intratumoral HSV-tk gene therapy – BIOENGINEER.ORG https://bioengineer.org Bioengineering Tue, 09 Sep 2025 09:51:33 +0000 en-US hourly 1 https://wordpress.org/?v=7.1.2 https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png intratumoral HSV-tk gene therapy – BIOENGINEER.ORG https://bioengineer.org 32 32 72741379 Novel Immunotherapy Approach Boosts Long-Term Survival in Advanced NSCLC Patients Resistant to Immune Checkpoint Inhibitors https://bioengineer.org/novel-immunotherapy-approach-boosts-long-term-survival-in-advanced-nsclc-patients-resistant-to-immune-checkpoint-inhibitors/ Tue, 09 Sep 2025 09:51:22 +0000 https://bioengineer.org/novel-immunotherapy-approach-boosts-long-term-survival-in-advanced-nsclc-patients-resistant-to-immune-checkpoint-inhibitors/ 267773